Office: Mrb 127
Phone: (970) 491-3353
Google Scholar: https://scholar.google.com/citations?user=mBEVGCkAAAAJ&hl=en
- Ph.D. Biochemistry, University of Colorado at Boulder
- M.S. Biochemistry, University of Colorado at Boulder
- B.S. Biochemistry, University of Massachusetts at Amherst
Concept Learning Inventories (CLIs) are powerful tools currently used in educational research in order measure student learning. Many CLIs have been developed for a variety of disciplines including physics, molecular biology, introductory biology, microbiology, etc. However, a CLI for a single semester biochemistry course, such as BC351, does not exist. My current reserach involves developing a Concept Learning Inventory for a single semester biochemistry course BC351. In addition, I currently teach Principles of Biochemistry BC351, Comprehensive Biochemistry Laboratory BC404 and mentor biochemistry students for their Thesis BC499. I also serve on the Undergraduate Affairs Committee and advise biochemistry students.
Defining the Significance of Insulin-like Growth Factor 2 mRNA-binding Protein 1 (IGF2BP1) Expression in both Human and Canine Osteosarcoma. FASEB Journal, Issue 1_supplement, 2019.
Principles of Biochemistry Great River Learning, 2016.
Transcription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors. PloS one, 7, 2013.
Anthracycline-Formaldehyde Conjugates and Their Targeted ProdrugsAnthracycline Chemistry and Biology II Springer, 2008.
Doxazolidine induction of apoptosis by a topoisomerase II independent mechanism Journal of Medicinal Chemistry, 2007.
Design, synthesis, and preliminary evaluation of doxazolidine carbamates as prodrugs activated by carboxylesterases Journal of Medicinal Chemistry, 2006.
Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells Journal of Medicinal Chemistry, 2004.
Doxorubicin-formaldehyde conjugates targeting αvB3 integrin Molecular Cancer Therapeutics, 2004.